First human test for new heart failure drug shows safety
Disease control
Completed
This was a small, early-stage study to check if a new drug called CDR132L is safe for people with stable heart failure caused by heart disease. It involved 28 patients and compared the drug to a placebo. The main goal was to see how the body processes the drug and to identify any…
Phase: PHASE1 • Sponsor: Cardior Pharmaceuticals GmbH • Aim: Disease control
Last updated Mar 25, 2026 14:08 UTC